We are live on
!
Find out more
TGIA
Torrey Growth & Income Advisors Portfolio holdings
AUM
$294M
1-Year Est. Return
37.95%
This Fund
S&P 500
This Quarter
Est. Return
-13.83%
1 Year Est. Return
+37.95%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$239M
AUM Growth
-$48.9M
(-17%)
Cap. Flow
+$396K
Cap. Flow
% of AUM
0.17%
Top 10 Holdings %
Top 10 Hldgs %
59.75%
Holding
117
New
7
Increased
35
Reduced
30
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$1.64M |
| 2 |
Trade Desk
TTD
|
+$1.04M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$848K |
| 4 |
Pfizer
PFE
|
+$497K |
| 5 |
Intellia Therapeutics
NTLA
|
+$428K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
EXAS
Exact Sciences
EXAS
|
+$1.54M |
| 2 |
American Express
AXP
|
+$1.34M |
| 3 |
Williams Companies
WMB
|
+$545K |
| 4 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$465K |
| 5 |
TEM
Tempus AI
TEM
|
+$296K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 60.28% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 6.35% |
| 4 | Consumer Discretionary | 4.59% |
| 5 | Consumer Staples | 2.75% |
Similar funds
PC
MFC
SM
BIC
TJHA
CA
PCI
MSWM
Torrey Growth & Income Advisors's Q1 2026 Portfolio in Review
As of Q1 2026, Torrey Growth & Income Advisors held 117 positions worth $239M, down 17% from $288M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Torrey Growth & Income Advisors's Q1 2026 filing shows 7 new, 35 increased, 30 reduced and 7 closed positions. Its largest new stake was ImmunityBio: 55,450 shares worth $405K. The largest sale was Exact Sciences, an estimated $1.54M.
By sector, the portfolio is most concentrated in Technology at 60% of assets, down from 63% a quarter earlier, followed by Healthcare and Financials.
- Torrey Growth & Income Advisors's largest Q1 2026 buy was ImmunityBio: 55,450 shares worth $405K.
- Torrey Growth & Income Advisors added most to Salesforce in Q1 2026, an estimated $1.64M increase.
- Torrey Growth & Income Advisors's biggest Q1 2026 reduction was American Express, cutting an estimated $1.34M.
- Torrey Growth & Income Advisors fully exited Exact Sciences in Q1 2026, selling an estimated $1.54M.
- Torrey Growth & Income Advisors's ten largest holdings make up 60% of its $239M portfolio in Q1 2026.
- Torrey Growth & Income Advisors opened 7 new positions and closed 7 in Q1 2026.
- Torrey Growth & Income Advisors's portfolio value fell 17% quarter-over-quarter to $239M.
Based on Torrey Growth & Income Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.